October 26, 2025 - 19:36

In recent developments, Luminar Technologies has highlighted its strategic partnerships with major automotive players such as Volvo, Mercedes-Benz, NVIDIA, and Mobileye. The company is set to unveil its next-generation Halo lidar chipset and production line by late 2025, with prototype production slated for early 2026. However, a noteworthy aspect of this announcement is the management's adjustment of the full-year 2025 guidance, which has been revised downward. This change is attributed to slower-than-expected automotive ramp-ups and the conclusion of legacy contracts.
Despite these challenges, Luminar remains optimistic about its technological advancements and the potential they hold for the future of autonomous driving. The company is focused on enhancing its product offerings and solidifying its position within the lidar market. As it navigates these transitional phases, the effectiveness of its partnerships and the successful rollout of new technologies will be crucial in determining its path to leadership in the lidar industry.
August 9, 2026 - 18:31
County agenda features tax, technology and fairgroundsThe meeting will center on how to fund the ongoing fairgrounds project, a long-discussed priority for the county. Officials are expected to review the latest cost estimates and possible revenue...
August 9, 2026 - 00:24
‘AI slop’ crackdown: LinkedIn, Snap target low-quality gen-AI contentSocial platforms are starting to push back against the flood of generic, machine-generated posts, but they are doing so carefully. LinkedIn and Snap have both announced new measures aimed at...
August 8, 2026 - 05:47
Why GigaCloud Technology (GCT) Is Up 21.7% After Strong Q2 Results And New Buyback PlanGigaCloud Technology saw its stock surge 21.7% in early trading following the release of its second-quarter financial results and the announcement of a new capital return program. The company...
August 7, 2026 - 22:40
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s SafetyOn August 5, 2026, the U.S. Food and Drug Administration gave the green light to the first messenger RNA flu vaccine for adults aged 50 and older. The decision came after a clinical trial involving...